ASBP Aspire Biopharma Holdings, Inc.
$9.06▼ -2.05%
Healthcare
Other
After hours
$9.06▲ +0.00%
Sep 11, 7:30 PM ET
Volume 26.8K
Avg Volume (10D) 40.0K
Key Metrics & Fundamentals
Market Cap
$12.71M
P/E Ratio
–
Div Yield
–%
52W Range
0.11 - 18.76
% vs 50 MA
22.28%
% vs 200 MA
124.22%
RSI-14
62.5
MACD Histogram
-0.0100
Beta (1Y vs SPY)
5.51
Free Cash Flow
-$2.12M
Gross Rev
$63,104
Gross Profit
-$30,086
EBITDA
-$2.39M
COGS
$93,190
Operating Exp
$2.42M
Operating Income
-$2.45M
EBIT
-$2.45M
Pretax Income
-$1.27M
Net Income
-$1.27M
EPS (Diluted)
-1.22
Price & Volume History
Loading chart…
Recent News
Aspire-Lakewood Holdings Board Approves $10 Million Share Repurchase Program
ACCESS Newswire · Sep 9, 2026 12:30 PM
Aspire Biopharma Holdings, INC. Announces Corporate Name Change To Aspire-Lakewood Holdings, Inc.
ACCESS Newswire · Sep 8, 2026 1:00 PM
Sidoti Events, LLC's August Micro-Cap Virtual Conference
ACCESS Newswire · Aug 18, 2026 2:00 PM
Aspire Biopharma Holdings, Inc., to Present at Sidoti Virtual Investor Conference August 19th
ACCESS Newswire · Aug 13, 2026 12:15 PM
EXCLUSIVE: Aspire Biopharma Buys Its Way Into Global Auto Market With $30 Million DCS Deal
Benzinga · Aug 11, 2026 2:31 AM
Aspire Biopharma Completes Acquisition of Dura Driver Control Systems, a Leading Global Automotive Supplier with a 100+ Year History and $200M+ in 2025 Revenue
ACCESS Newswire · Aug 10, 2026 12:30 PM
Freestyle Motocross Legend Jarryd McNeil Named Newest Sponsored Athlete for Aspire Biopharma's BUZZ BOMB(TM)
ACCESS Newswire · Jul 20, 2026 12:30 PM
OTC Markets Life Sciences Investor Forum: Stephen Quesenberry, General Counsel and Director of Product Development, of Aspire Biopharma with Zacks SCR’s David Bautz, PhD
Zacks Small Cap Research · Jul 10, 2026 10:33 AM
Life Sciences Virtual Investor Forum Presentations Now Available for On-Demand Viewing
GlobeNewswire · Jun 26, 2026 12:35 PM
Aspire Biopharma's BUZZ BOMB(TM) Launches on Amazon, Introducing Next-Generation Caffeine Stick Packs
ACCESS Newswire · Jun 24, 2026 12:30 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See ASBP's money flow as a full page
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.